IndustryCompany release

Butterfly Network lifts 2026 revenue guidance after Q3 sales rise 52% to $32.6m

🇺🇸 Butterfly Network, Inc. (BFLY) · Thu 29 Oct 2026

The maker of semiconductor-based ultrasound devices reported a record 73% gross margin and a narrower net loss, and said it has secured FedRAMP authorization.

Butterfly Network (NYSE: BFLY) reported results for the quarter ended 30 September 2026, with revenue up 52% to $32.6 million. The company said Embedded licensing contributed to the increase. It also reported a record gross margin of 73%.

Net loss narrowed to $12.8 million in the quarter. The company did not give further detail in the material available to VigiEye, so a comparison with earlier periods is not possible here.

Butterfly raised its full-year 2026 revenue guidance to a range of $123 million to $126 million. It also said it has achieved FedRAMP authorization. FedRAMP is the US federal programme that standardises security assessment and authorisation for cloud services used by government agencies.

Management discussed the results on a conference call on 29 October 2026. The full text of the release was not available when this article was prepared, so segment detail and the earlier guidance range are not covered.

What it means for your team

  • Teams assessing point-of-care ultrasound suppliers can note the company's raised 2026 revenue outlook of $123-126 million and its narrower quarterly net loss.
  • FedRAMP authorization may matter to organisations that need US federal-grade security assurance for cloud-connected imaging or software services.
  • The company credits Embedded licensing as a contributor to growth, so partners and customers may want to follow how that model develops. No regulatory or product-safety developments were reported in this item.

Company's press release (SEC filing): Butterfly Network, Inc. ↗

Article written by VigiEye from the official source (Butterfly Network, Inc.). Claims are the company's own. AI-assisted; check the source before acting.

More Industry All →